Filing Details

Accession Number:
0000711377-21-000016
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-14 18:18:55
Reporting Period:
2021-04-14
Accepted Time:
2021-04-14 18:18:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1517426 J. Steven Quinlan 620 Lesher Place
Lansing MI 48912
Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-14 13,001 $60.43 26,471 No 4 M Direct
Common Stock Disposition 2021-04-14 13,001 $93.93 13,470 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2021-04-14 13,001 $0.00 13,001 $60.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
103,998 2022-11-27 No 4 M Direct
Footnotes
  1. Options were granted on 10/27/2017, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant